Cantor Fitzgerald Issues Positive Forecast for Hyperliquid Strategies (NASDAQ:PURR) Stock Price

Hyperliquid Strategies (NASDAQ:PURR) had its price objective hoisted by equities researchers at Cantor Fitzgerald from $22.60 to $34.20 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Cantor Fitzgerald’s price target would indicate a potential upside of 184.29% from the stock’s current price.

Several other equities research analysts also recently commented on PURR. Chardan Capital boosted their target price on shares of Hyperliquid Strategies from $9.75 to $17.00 and gave the stock a “buy” rating in a research report on Friday, August 28th. Wall Street Zen downgraded Hyperliquid Strategies from a “hold” rating to a “sell” rating in a research note on Saturday, August 29th. Finally, Weiss Ratings raised Hyperliquid Strategies from a “sell (d+)” rating to a “hold (c)” rating in a report on Friday, August 28th. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Hyperliquid Strategies currently has an average rating of “Moderate Buy” and an average price target of $20.40.

Hyperliquid Strategies Stock Up 0.8%

Shares of NASDAQ:PURR opened at $12.03 on Thursday. Hyperliquid Strategies has a twelve month low of $3.01 and a twelve month high of $14.14. The stock’s 50 day moving average is $8.45 and its 200-day moving average is $7.32. The firm has a market capitalization of $2.38 billion, a price-to-earnings ratio of -1.87 and a beta of 1.89.

Institutional Trading of Hyperliquid Strategies

Institutional investors and hedge funds have recently made changes to their positions in the company. State of Wyoming bought a new position in shares of Hyperliquid Strategies during the second quarter valued at about $46,000. Shepherd Financial Partners LLC bought a new stake in Hyperliquid Strategies in the 2nd quarter worth about $79,000. Boothbay Fund Management LLC purchased a new stake in Hyperliquid Strategies in the 4th quarter valued at about $40,000. Lotus Technology Management LP purchased a new stake in Hyperliquid Strategies in the 2nd quarter valued at about $93,000. Finally, XTX Topco Ltd bought a new position in shares of Hyperliquid Strategies during the 4th quarter worth approximately $48,000. Hedge funds and other institutional investors own 9.45% of the company’s stock.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.